Key Takeaways Tesamorelin IS FDA-approved Unlike BPC-157 or TB-500, tesamorelin has full FDA approval under the brand name Egrifta Approved indication: HIV-associated lipodystrophy (reduction of excess abdominal visceral adipose tissue) Original approval: November 2010 by Theratechnologies Inc
Stimulates immune function
Neuroendocrine Modulation: Influences pituitary release of GH, LH, and ACTH [Kastin 1990]
Recently published lines of evidence suggest a role for pannexin 1 (Px1) as one component in the release of ATP from RBCs ( in vivo and into the supernatant in vitro ( via adenosine receptors promotes deoxygenation of sickle hemoglobin and in turn (HbS) polymerization and RBC sickling
A 2022 review found oxidative stress may lead to the progression of: neurodegenerative diseases, such as Alzheimers heart disease chronic kidney disease cancer type 2 diabetes obesity Other characteristics from a 2020 review of carotenoids include: anti-inflammatory agent immune system-boosting increasing bone density Lutein may also help prevent nonalcoholic fatty liver disease (NAFLD)
Ferroptosis: Mechanisms, biology and role in disease
